{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:35:18Z","timestamp":1792794918295,"version":"4.5.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":56,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-71197-2","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T16:09:21Z","timestamp":1775059761000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["YY1\/Asprosin\/PFKP axis regulates glycolytic metabolic and exacerbates pathological cardiac hypertrophy"],"prefix":"10.1038","volume":"17","author":[{"given":"Ming","family":"Tong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangfei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linhe","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanrong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengkai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shifeng","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honglin","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixiu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0346-2863","authenticated-orcid":false,"given":"Zhimin","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6416-4360","authenticated-orcid":false,"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"71197_CR1","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1161\/CIRCHEARTFAILURE.114.001469","volume":"7","author":"L Lai","year":"2014","unstructured":"Lai, L. et al. Energy metabolic reprogramming in the hypertrophied and early stage failing heart: a multisystems approach. Circ. Heart Fail 7, 1022\u20131031 (2014).","journal-title":"Circ. Heart Fail"},{"key":"71197_CR2","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0735-1097(02)01967-8","volume":"40","author":"VG D\u00e1vila-Rom\u00e1n","year":"2002","unstructured":"D\u00e1vila-Rom\u00e1n, V. G. et al. Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy. J. Am. Coll. Cardiol. 40, 271\u2013277 (2002).","journal-title":"J. Am. Coll. Cardiol."},{"key":"71197_CR3","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1161\/CIRCRESAHA.113.302095","volume":"113","author":"SC Kolwicz Jr.","year":"2013","unstructured":"Kolwicz, S. C. Jr., Purohit, S. & Tian, R. Cardiac metabolism and its interactions with contraction, growth, and survival of cardiomyocytes. Circ. Res. 113, 603\u2013616 (2013).","journal-title":"Circ. Res."},{"key":"71197_CR4","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1093\/cvr\/cvx017","volume":"113","author":"J Ritterhoff","year":"2017","unstructured":"Ritterhoff, J. & Tian, R. Metabolism in cardiomyopathy: every substrate matters. Cardiovasc. Res. 113, 411\u2013421 (2017).","journal-title":"Cardiovasc. Res."},{"key":"71197_CR5","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1056\/NEJMra063052","volume":"356","author":"S Neubauer","year":"2007","unstructured":"Neubauer, S. The failing heart\u2014an engine out of fuel. N. Engl. J. Med. 356, 1140\u20131151 (2007).","journal-title":"N. Engl. J. Med."},{"key":"71197_CR6","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1161\/CIRCRESAHA.116.305420","volume":"116","author":"RB Vega","year":"2015","unstructured":"Vega, R. B., Horton, J. L. & Kelly, D. P. Maintaining ancient organelles: mitochondrial biogenesis and maturation. Circ. Res. 116, 1820\u20131834 (2015).","journal-title":"Circ. Res."},{"key":"71197_CR7","doi-asserted-by":"publisher","first-page":"H2889","DOI":"10.1152\/ajpheart.91501.2007","volume":"294","author":"Q Wang","year":"2008","unstructured":"Wang, Q. et al. Cardiac phosphatase-deficient 6-phosphofructo-2-kinase\/fructose-2,6-bisphosphatase increases glycolysis, hypertrophy, and myocyte resistance to hypoxia. Am. J. Physiol. Heart Circ. Physiol. 294, H2889\u2013H2897 (2008).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"71197_CR8","first-page":"H742","volume":"267","author":"MF Allard","year":"1994","unstructured":"Allard, M. F., Sch\u00f6nekess, B. O., Henning, S. L., English, D. R. & Lopaschuk, G. D. Contribution of oxidative metabolism and glycolysis to ATP production in hypertrophied hearts. Am. J. Physiol. 267, H742\u2013H750 (1994).","journal-title":"Am. J. Physiol."},{"key":"71197_CR9","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1161\/CIRCULATIONAHA.105.534594","volume":"112","author":"I Luptak","year":"2005","unstructured":"Luptak, I. et al. Decreased contractile and metabolic reserve in peroxisome proliferator-activated receptor-alpha-null hearts can be rescued by increasing glucose transport and utilization. Circulation 112, 2339\u20132346 (2005).","journal-title":"Circulation"},{"key":"71197_CR10","doi-asserted-by":"publisher","first-page":"H3270","DOI":"10.1152\/ajpheart.00887.2007","volume":"293","author":"D Neglia","year":"2007","unstructured":"Neglia, D. et al. Impaired myocardial metabolic reserve and substrate selection flexibility during stress in patients with idiopathic dilated cardiomyopathy. Am. J. Physiol. Heart Circ. Physiol. 293, H3270\u2013H3278 (2007).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"71197_CR11","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1161\/01.CIR.96.2.676","volume":"96","author":"MF Allard","year":"1997","unstructured":"Allard, M. F. et al. Glycogen metabolism in the aerobic hypertrophied rat heart. Circulation 96, 676\u2013682 (1997).","journal-title":"Circulation"},{"key":"71197_CR12","doi-asserted-by":"publisher","first-page":"E1039","DOI":"10.1152\/ajpendo.00507.2001","volume":"282","author":"HS Leong","year":"2002","unstructured":"Leong, H. S. et al. Accelerated rates of glycolysis in the hypertrophied heart: are they a methodological artifact? Am. J. Physiol. Endocrinol. Metab. 282, E1039\u2013E1045 (2002).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"71197_CR13","first-page":"H1615","volume":"272","author":"Z El Alaoui-Talibi","year":"1997","unstructured":"El Alaoui-Talibi, Z., Guendouz, A., Moravec, M. & Moravec, J. Control of oxidative metabolism in volume-overloaded rat hearts: effect of propionyl-L-carnitine. Am. J. Physiol. 272, H1615\u2013H1624 (1997).","journal-title":"Am. J. Physiol."},{"key":"71197_CR14","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1016\/S0735-1097(00)00856-1","volume":"36","author":"RB Wambolt","year":"2000","unstructured":"Wambolt, R. B., Lopaschuk, G. D., Brownsey, R. W. & Allard, M. F. Dichloroacetate improves postischemic function of hypertrophied rat hearts. J. Am. Coll. Cardiol. 36, 1378\u20131385 (2000).","journal-title":"J. Am. Coll. Cardiol."},{"key":"71197_CR15","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/cvr\/cvn301","volume":"81","author":"JS Ingwall","year":"2009","unstructured":"Ingwall, J. S. Energy metabolism in heart failure and remodelling. Cardiovasc. Res. 81, 412\u2013419 (2009).","journal-title":"Cardiovasc. Res."},{"key":"71197_CR16","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1161\/01.RES.0000137170.41939.d9","volume":"95","author":"JS Ingwall","year":"2004","unstructured":"Ingwall, J. S. & Weiss, R. G. Is the failing heart energy starved? On using chemical energy to support cardiac function. Circ. Res. 95, 135\u2013145 (2004).","journal-title":"Circ. Res."},{"key":"71197_CR17","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1161\/CIRCULATIONAHA.118.037803","volume":"139","author":"H Ma","year":"2019","unstructured":"Ma, H. et al. Lin28a regulates pathological cardiac hypertrophic growth through Pck2-mediated enhancement of anabolic synthesis. Circulation 139, 1725\u20131740 (2019).","journal-title":"Circulation"},{"key":"71197_CR18","doi-asserted-by":"crossref","unstructured":"Zhou, B. et al. Upregulation of mitochondrial ATPase inhibitory factor 1 (ATPIF1) mediates increased glycolysis in mouse hearts. J. Clin. Invest. 132, e155333 (2022).","DOI":"10.1172\/JCI155333"},{"key":"71197_CR19","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1038\/nm.4432","volume":"23","author":"C Duerrschmid","year":"2017","unstructured":"Duerrschmid, C. et al. Asprosin is a centrally acting orexigenic hormone. Nat. Med 23, 1444\u20131453 (2017).","journal-title":"Nat. Med"},{"key":"71197_CR20","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3389\/fendo.2020.00064","volume":"11","author":"M Yuan","year":"2020","unstructured":"Yuan, M., Li, W., Zhu, Y., Yu, B. & Wu, J. Asprosin: a novel player in metabolic diseases. Front Endocrinol. 11, 64 (2020).","journal-title":"Front Endocrinol."},{"key":"71197_CR21","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.cell.2016.02.063","volume":"165","author":"C Romere","year":"2016","unstructured":"Romere, C. et al. Asprosin, a fasting-induced glucogenic protein hormone. Cell 165, 566\u2013579 (2016).","journal-title":"Cell"},{"key":"71197_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1101091","volume":"13","author":"M Farrag","year":"2022","unstructured":"Farrag, M. et al. Asprosin in health and disease, a new glucose sensor with central and peripheral metabolic effects. Front Endocrinol. 13, 1101091 (2022).","journal-title":"Front Endocrinol."},{"key":"71197_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.131868","volume":"268","author":"Y Zhao","year":"2024","unstructured":"Zhao, Y. et al. Asprosin aggravates atherosclerosis via regulating the phenotype transformation of vascular smooth muscle cells. Int J. Biol. Macromol. 268, 131868 (2024).","journal-title":"Int J. Biol. Macromol."},{"key":"71197_CR24","doi-asserted-by":"publisher","DOI":"10.1111\/and.14579","volume":"54","author":"S Maurya","year":"2022","unstructured":"Maurya, S., Krishna, A., Lal, B. & Singh, A. Asprosin promotes steroidogenesis and spermatogenesis with improved glucose metabolism in adult mice testis. Andrologia 54, e14579 (2022).","journal-title":"Andrologia"},{"key":"71197_CR25","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.cmet.2019.05.022","volume":"30","author":"E Li","year":"2019","unstructured":"Li, E. et al. OLFR734 mediates glucose metabolism as a receptor of asprosin. Cell Metab. 30, 319\u2013328.e318 (2019).","journal-title":"Cell Metab."},{"key":"71197_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.689747","volume":"12","author":"D Lagarde","year":"2021","unstructured":"Lagarde, D. et al. Lactate fluxes and plasticity of adipose tissues: a redox perspective. Front Physiol. 12, 689747 (2021).","journal-title":"Front Physiol."},{"key":"71197_CR27","doi-asserted-by":"publisher","first-page":"42351","DOI":"10.1074\/jbc.R400019200","volume":"279","author":"RP Robertson","year":"2004","unstructured":"Robertson, R. P. Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. J. Biol. Chem. 279, 42351\u201342354 (2004).","journal-title":"J. Biol. Chem."},{"key":"71197_CR28","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.taap.2006.01.003","volume":"212","author":"AP Rolo","year":"2006","unstructured":"Rolo, A. P. & Palmeira, C. M. Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress. Toxicol. Appl. Pharm. 212, 167\u2013178 (2006).","journal-title":"Toxicol. Appl. Pharm."},{"key":"71197_CR29","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1007\/s00125-010-1770-4","volume":"53","author":"A Makino","year":"2010","unstructured":"Makino, A., Scott, B. T. & Dillmann, W. H. Mitochondrial fragmentation and superoxide anion production in coronary endothelial cells from a mouse model of type 1 diabetes. Diabetologia 53, 1783\u20131794 (2010).","journal-title":"Diabetologia"},{"key":"71197_CR30","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.freeradbiomed.2011.10.441","volume":"52","author":"J Styskal","year":"2012","unstructured":"Styskal, J., Van Remmen, H., Richardson, A. & Salmon, A. B. Oxidative stress and diabetes: what can we learn about insulin resistance from antioxidant mutant mouse models? Free Radic. Biol. Med. 52, 46\u201358 (2012).","journal-title":"Free Radic. Biol. Med."},{"key":"71197_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-024-01767-z","volume":"26","author":"ZM Peng","year":"2024","unstructured":"Peng, Z. M. et al. PFKP deubiquitination and stabilization by USP5 activate aerobic glycolysis to promote triple-negative breast cancer progression. Breast Cancer Res. 26, 10 (2024).","journal-title":"Breast Cancer Res."},{"key":"71197_CR32","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1038\/s41418-020-0523-2","volume":"27","author":"N Zhang","year":"2020","unstructured":"Zhang, N. et al. Selective targeting of ubiquitination and degradation of PARP1 by E3 ubiquitin ligase WWP2 regulates isoproterenol-induced cardiac remodeling. Cell Death Differ. 27, 2605\u20132619 (2020).","journal-title":"Cell Death Differ."},{"key":"71197_CR33","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/cdd.2012.72","volume":"20","author":"S Shaid","year":"2013","unstructured":"Shaid, S., Brandts, C. H., Serve, H. & Dikic, I. Ubiquitination and selective autophagy. Cell Death Differ. 20, 21\u201330 (2013).","journal-title":"Cell Death Differ."},{"key":"71197_CR34","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1038\/ni.3279","volume":"16","author":"Y Zhang","year":"2015","unstructured":"Zhang, Y. et al. PARP9-DTX3L ubiquitin ligase targets host histone H2BJ and viral 3C protease to enhance interferon signaling and control viral infection. Nat. Immunol. 16, 1215\u20131227 (2015).","journal-title":"Nat. Immunol."},{"key":"71197_CR35","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1161\/CIRCRESAHA.108.189951","volume":"104","author":"KM Pound","year":"2009","unstructured":"Pound, K. M. et al. Substrate-enzyme competition attenuates upregulated anaplerotic flux through malic enzyme in hypertrophied rat heart and restores triacylglyceride content: attenuating upregulated anaplerosis in hypertrophy. Circ. Res 104, 805\u2013812 (2009).","journal-title":"Circ. Res"},{"key":"71197_CR36","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41569-018-0044-6","volume":"15","author":"E Bertero","year":"2018","unstructured":"Bertero, E. & Maack, C. Metabolic remodelling in heart failure. Nat. Rev. Cardiol. 15, 457\u2013470 (2018).","journal-title":"Nat. Rev. Cardiol."},{"key":"71197_CR37","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3389\/fcvm.2018.00068","volume":"5","author":"QG Karwi","year":"2018","unstructured":"Karwi, Q. G., Uddin, G. M., Ho, K. L. & Lopaschuk, G. D. Loss of metabolic flexibility in the failing heart. Front Cardiovasc. Med. 5, 68 (2018).","journal-title":"Front Cardiovasc. Med."},{"key":"71197_CR38","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.012673","volume":"8","author":"DH Tran","year":"2019","unstructured":"Tran, D. H. & Wang, Z. V. Glucose metabolism in cardiac hypertrophy and heart failure. J. Am. Heart Assoc. 8, e012673 (2019).","journal-title":"J. Am. Heart Assoc."},{"key":"71197_CR39","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1203\/01.PDR.0000057987.46622.64","volume":"53","author":"F Fouque","year":"2003","unstructured":"Fouque, F. et al. Differential effect of DCA treatment on the pyruvate dehydrogenase complex in patients with severe PDHC deficiency. Pediatr. Res. 53, 793\u2013799 (2003).","journal-title":"Pediatr. Res."},{"key":"71197_CR40","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1093\/cvr\/cvad038","volume":"119","author":"MJ Forteza","year":"2023","unstructured":"Forteza, M. J. et al. Pyruvate dehydrogenase kinase regulates vascular inflammation in atherosclerosis and increases cardiovascular risk. Cardiovasc. Res. 119, 1524\u20131536 (2023).","journal-title":"Cardiovasc. Res."},{"key":"71197_CR41","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.125.041401","volume":"14","author":"X Hua","year":"2025","unstructured":"Hua, X. et al. Pyruvate dehydrogenase kinase 4 underlies the metabolic disorder of cardiomyocytes in patients with hypertrophic cardiomyopathy from hypertrophy to heart failure. J. Am. Heart Assoc. 14, e041401 (2025).","journal-title":"J. Am. Heart Assoc."},{"key":"71197_CR42","doi-asserted-by":"publisher","first-page":"H1103","DOI":"10.1152\/ajpheart.00636.2012","volume":"304","author":"J Mori","year":"2013","unstructured":"Mori, J. et al. ANG II causes insulin resistance and induces cardiac metabolic switch and inefficiency: a critical role of PDK4. Am. J. Physiol. Heart Circ. Physiol. 304, H1103\u2013H1113 (2013).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"71197_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56885-9","volume":"16","author":"K Zhang","year":"2025","unstructured":"Zhang, K. et al. FGF21 protects against HFpEF by improving cardiac mitochondrial bioenergetics in mice. Nat. Commun. 16, 1661 (2025).","journal-title":"Nat. Commun."},{"key":"71197_CR44","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1161\/CIRCRESAHA.120.316443","volume":"126","author":"L Tian","year":"2020","unstructured":"Tian, L. et al. Epigenetic metabolic reprogramming of right ventricular fibroblasts in pulmonary arterial hypertension: a pyruvate dehydrogenase kinase-dependent shift in mitochondrial metabolism promotes right ventricular fibrosis. Circ. Res. 126, 1723\u20131745 (2020).","journal-title":"Circ. Res."},{"key":"71197_CR45","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/nature05602","volume":"446","author":"M Sano","year":"2007","unstructured":"Sano, M. et al. p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload. Nature 446, 444\u2013448 (2007).","journal-title":"Nature"},{"key":"71197_CR46","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/nature14508","volume":"522","author":"P Mirtschink","year":"2015","unstructured":"Mirtschink, P. et al. HIF-driven SF3B1 induces KHK-C to enforce fructolysis and heart disease. Nature 522, 444\u2013449 (2015).","journal-title":"Nature"},{"key":"71197_CR47","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1161\/CIRCULATIONAHA.106.637124","volume":"114","author":"YG Ni","year":"2006","unstructured":"Ni, Y. G. et al. Foxo transcription factors blunt cardiac hypertrophy by inhibiting calcineurin signaling. Circulation 114, 1159\u20131168 (2006).","journal-title":"Circulation"},{"key":"71197_CR48","doi-asserted-by":"publisher","first-page":"20814","DOI":"10.1074\/jbc.M500528200","volume":"280","author":"C Skurk","year":"2005","unstructured":"Skurk, C. et al. The FOXO3a transcription factor regulates cardiac myocyte size downstream of AKT signaling. J. Biol. Chem. 280, 20814\u201320823 (2005).","journal-title":"J. Biol. Chem."},{"key":"71197_CR49","doi-asserted-by":"publisher","first-page":"5035","DOI":"10.1158\/0008-5472.CAN-12-0979","volume":"72","author":"J Kluza","year":"2012","unstructured":"Kluza, J. et al. Inactivation of the HIF-1\u03b1\/PDK3 signaling axis drives melanoma toward mitochondrial oxidative metabolism and potentiates the therapeutic activity of pro-oxidants. Cancer Res. 72, 5035\u20135047 (2012).","journal-title":"Cancer Res."},{"key":"71197_CR50","doi-asserted-by":"publisher","first-page":"328","DOI":"10.4093\/dmj.2012.36.5.328","volume":"36","author":"JY Jeong","year":"2012","unstructured":"Jeong, J. Y., Jeoung, N. H., Park, K. G. & Lee, I. K. Transcriptional regulation of pyruvate dehydrogenase kinase. Diab. Metab. J. 36, 328\u2013335 (2012).","journal-title":"Diab. Metab. J."},{"key":"71197_CR51","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1161\/CIRCULATIONAHA.120.051094","volume":"144","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y. et al. HINT1 (histidine triad nucleotide-binding protein 1) attenuates cardiac hypertrophy via suppressing HOXA5 (Homeobox A5) expression. Circulation 144, 638\u2013654 (2021).","journal-title":"Circulation"},{"key":"71197_CR52","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.yjmcc.2019.12.013","volume":"139","author":"Y Xu","year":"2020","unstructured":"Xu, Y., Luo, Y., Liang, C. & Zhang, T. LncRNA-Mhrt regulates cardiac hypertrophy by modulating the miR-145a-5p\/KLF4\/myocardin axis. J. Mol. Cell Cardiol. 139, 47\u201361 (2020).","journal-title":"J. Mol. Cell Cardiol."},{"key":"71197_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-022-03642-x","volume":"20","author":"J Hu","year":"2022","unstructured":"Hu, J. et al. Omentin1 ameliorates myocardial ischemia-induced heart failure via SIRT3\/FOXO3a-dependent mitochondrial dynamical homeostasis and mitophagy. J. Transl. Med. 20, 447 (2022).","journal-title":"J. Transl. Med."},{"key":"71197_CR54","first-page":"327","volume":"7","author":"J Molina","year":"1985","unstructured":"Molina, J. Fentiazac in acute gouty arthritis. Clin. Ther. 7, 327\u2013333 (1985).","journal-title":"Clin. Ther."},{"key":"71197_CR55","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1016\/j.ymthe.2020.06.026","volume":"28","author":"Y Nakamura","year":"2020","unstructured":"Nakamura, Y. et al. Adiponectin stimulates exosome release to enhance mesenchymal stem-cell-driven therapy of heart failure in mice. Mol. Ther. 28, 2203\u20132219 (2020).","journal-title":"Mol. Ther."},{"key":"71197_CR56","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202308769","volume":"11","author":"S Yu","year":"2024","unstructured":"Yu, S. et al. The m7G methyltransferase Mettl1 drives cardiac hypertrophy by regulating SRSF9-mediated splicing of NFATc4. Adv. Sci. 11, e2308769 (2024).","journal-title":"Adv. Sci."},{"key":"71197_CR57","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.cca.2017.10.034","volume":"489","author":"L Zhang","year":"2019","unstructured":"Zhang, L., Chen, C., Zhou, N., Fu, Y. & Cheng, X. Circulating asprosin concentrations are increased in type 2 diabetes mellitus and independently associated with fasting glucose and triglyceride. Clin. Chim. Acta 489, 183\u2013188 (2019).","journal-title":"Clin. Chim. Acta"},{"key":"71197_CR58","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/jdi.13148","volume":"11","author":"X Zhang","year":"2020","unstructured":"Zhang, X., Jiang, H., Ma, X. & Wu, H. Increased serum level and impaired response to glucose fluctuation of asprosin is associated with type 2 diabetes mellitus. J. Diab. Investig. 11, 349\u2013355 (2020).","journal-title":"J. Diab. Investig."},{"key":"71197_CR59","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13098-020-00564-w","volume":"12","author":"S Naiemian","year":"2020","unstructured":"Naiemian, S. et al. Serum concentration of asprosin in new-onset type 2 diabetes. Diabetol. Metab. Syndr. 12, 65 (2020).","journal-title":"Diabetol. Metab. Syndr."},{"key":"71197_CR60","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1186\/s12872-023-03668-z","volume":"23","author":"G Wang","year":"2023","unstructured":"Wang, G. et al. Association of serum Asprosin concentrations with heart failure. BMC Cardiovasc. Disord. 23, 617 (2023).","journal-title":"BMC Cardiovasc. Disord."},{"key":"71197_CR61","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1186\/s12872-020-01680-1","volume":"20","author":"MS Wen","year":"2020","unstructured":"Wen, M. S. et al. The role of Asprosin in patients with dilated cardiomyopathy. BMC Cardiovasc. Disord. 20, 402 (2020).","journal-title":"BMC Cardiovasc. Disord."},{"key":"71197_CR62","doi-asserted-by":"publisher","first-page":"C377","DOI":"10.1152\/ajpcell.01006.2024","volume":"329","author":"Y Wang","year":"2025","unstructured":"Wang, Y. et al. Asprosin attenuates diabetic cardiomyopathy through inhibiting autophagy mediated by AMPK\/mTOR\/ULK1 pathway. Am. J. Physiol. Cell Physiol. 329, C377\u2013C394 (2025).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"71197_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2019.116554","volume":"231","author":"Z Zhang","year":"2019","unstructured":"Zhang, Z. et al. Asprosin improves the survival of mesenchymal stromal cells in myocardial infarction by inhibiting apoptosis via the activated ERK1\/2-SOD2 pathway. Life Sci. 231, 116554 (2019).","journal-title":"Life Sci."},{"key":"71197_CR64","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41392-020-00445-8","volume":"6","author":"X Zhang","year":"2021","unstructured":"Zhang, X. et al. The double face of miR-320: cardiomyocytes-derived miR-320 deteriorated while fibroblasts-derived miR-320 protected against heart failure induced by transverse aortic constriction. Signal Transduct. Target Ther. 6, 69 (2021).","journal-title":"Signal Transduct. Target Ther."},{"key":"71197_CR65","doi-asserted-by":"crossref","unstructured":"Beck, C. et al. Asprosin as a potential new paracrine regulator in the heart. Cardiovasc. Res. 120, cvae088-217 (2024).","DOI":"10.1093\/cvr\/cvae088.217"},{"key":"71197_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2023.101751","volume":"36","author":"Q Wang","year":"2023","unstructured":"Wang, Q. et al. Long noncoding RNA BBOX1-AS1 increased radiotherapy sensitivity in colorectal cancer by stabilizing and activating PFK1. Transl. Oncol. 36, 101751 (2023).","journal-title":"Transl. Oncol."},{"key":"71197_CR67","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s00395-023-01018-w","volume":"118","author":"S Chen","year":"2023","unstructured":"Chen, S. et al. The role of glycolytic metabolic pathways in cardiovascular disease and potential therapeutic approaches. Basic Res. Cardiol. 118, 48 (2023).","journal-title":"Basic Res. Cardiol."},{"key":"71197_CR68","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/S0022-3476(86)80302-X","volume":"109","author":"SD Barnes","year":"1986","unstructured":"Barnes, S. D., Grob, C. S., Lachman, B. S., Marsh, B. R. & Loughlin, G. M. Psychogenic upper airway obstruction presenting as refractory wheezing. J. Pediatr. 109, 1067\u20131070 (1986).","journal-title":"J. Pediatr."},{"key":"71197_CR69","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1093\/cvr\/cvaa233","volume":"117","author":"M Vigil-Garcia","year":"2021","unstructured":"Vigil-Garcia, M. et al. Gene expression profiling of hypertrophic cardiomyocytes identifies new players in pathological remodelling. Cardiovasc. Res. 117, 1532\u20131545 (2021).","journal-title":"Cardiovasc. Res."},{"key":"71197_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2024.167542","volume":"1871","author":"XY Wu","year":"2025","unstructured":"Wu, X. Y. et al. PFKP inhibition protects against pathological cardiac hypertrophy by regulating protein synthesis. Biochim. Biophys. Acta Mol. Basis Dis. 1871, 167542 (2025).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"71197_CR71","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.yjmcc.2019.11.146","volume":"138","author":"J Gao","year":"2020","unstructured":"Gao, J. et al. The involvement of post-translational modifications in cardiovascular pathologies: focus on SUMOylation, neddylation, succinylation, and prenylation. J. Mol. Cell Cardiol. 138, 49\u201358 (2020).","journal-title":"J. Mol. Cell Cardiol."},{"key":"71197_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-43982-2","volume":"13","author":"J Peng","year":"2023","unstructured":"Peng, J. et al. PFKP is a prospective prognostic, diagnostic, immunological and drug sensitivity predictor across pan-cancer. Sci. Rep. 13, 17399 (2023).","journal-title":"Sci. Rep."},{"key":"71197_CR73","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00906-9","volume":"8","author":"JH Lee","year":"2017","unstructured":"Lee, J. H. et al. Stabilization of phosphofructokinase 1 platelet isoform by AKT promotes tumorigenesis. Nat. Commun. 8, 949 (2017).","journal-title":"Nat. Commun."},{"key":"71197_CR74","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-020-00679-7","volume":"19","author":"Y Fan","year":"2021","unstructured":"Fan, Y. et al. Anti-Warburg effect by targeting HRD1-PFKP pathway may inhibit breast cancer progression. Cell Commun. Signal 19, 18 (2021).","journal-title":"Cell Commun. Signal"},{"key":"71197_CR75","doi-asserted-by":"publisher","first-page":"H936","DOI":"10.1152\/ajpheart.00870.2007","volume":"294","author":"G Zhao","year":"2008","unstructured":"Zhao, G. et al. Overexpression of pyruvate dehydrogenase kinase 4 in heart perturbs metabolism and exacerbates calcineurin-induced cardiomyopathy. Am. J. Physiol. Heart Circ. Physiol. 294, H936\u2013H943 (2008).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"71197_CR76","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1161\/CIRCRESAHA.116.309202","volume":"119","author":"M Ackers-Johnson","year":"2016","unstructured":"Ackers-Johnson, M. et al. A simplified, Langendorff-free method for concomitant isolation of viable cardiac myocytes and nonmyocytes from the adult mouse heart. Circ. Res .119, 909\u2013920 (2016).","journal-title":"Circ. Res"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-71197-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-71197-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-71197-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T01:04:05Z","timestamp":1779843845000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-71197-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["71197"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-71197-2","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"assertion":[{"value":"20 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4718"}}